Tonix Pharmaceuticals Holding Corp. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXP4d

   Tonix Pharmaceuticals reports Q3 2026 revenue estimates

   • Net revenue for TONMYA estimated between $14.0M and $15.0M
   • Cash and cash equivalents as of Sept 30, 2026: ~$162.8M
   • Preliminary results subject to revision
2. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPOct 2

   Tonix Pharmaceuticals faces generic challenge

   • Received notice from Dr. Reddy's Labs about ANDA filing for TONMYA
   • ANDA includes Paragraph IV patent certification for four TONMYA patents
   • Patents listed in FDA's Orange Book: 9636408, 9956188, 10117936, 10864175
3. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPSep 22

   Current report

4. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPSep 8

   Current report

5. ROUTINE3Tonix Pharmaceuticals Holding Corp.TNXPSep 8

   Thomas Englese, new insider at TNXP

   Thomas Englese, reporting

6. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPAug 31

   Seth Lederman, insider filing for TNXP

   Seth Lederman, reporting

7. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPAug 24

   Richard H Bagger, insider filing for TNXP

   Richard H Bagger, reporting

8. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPAug 18

   Current report

9. ROUTINESCHEDULE 13G/ATonix Pharmaceuticals Holding Corp.TNXPAug 14

   Ownership stake disclosure by Sirenia Capital Management LP (amended)

   Sirenia Capital Management LP, filed by

10. ROUTINESCHEDULE 13GTonix Pharmaceuticals Holding Corp.TNXPAug 13

    Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC

    AQR CAPITAL MANAGEMENT LLC, filed by

11. NOTABLE10-QTonix Pharmaceuticals Holding Corp.TNXPAug 10

    Quarterly report

12. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPAug 10

    Current report

13. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPAug 3

    Current report

14. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPJul 21

    Current report

15. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPJul 13

    Current report

16. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPJul 9

    Bradley Saenger, insider filing for TNXP

    Bradley Saenger, reporting

17. ROUTINES-8Tonix Pharmaceuticals Holding Corp.TNXPJul 1

    Employee stock plan registration

18. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPJun 29

    Current report

19. ROUTINESCHEDULE 13GTonix Pharmaceuticals Holding Corp.TNXPJun 15

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

20. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPJun 15

    Carolyn E. Taylor, insider filing for TNXP

    Carolyn E. Taylor, reporting

21. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPJun 9

    2 insider filings

    Seth Lederman, insider filing for TNXP

    Show all 2

    • 4Insider filing for TNXPJun 9
    • 4Insider filing for TNXPJun 9

    Seth Lederman, reporting

22. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPJun 8

    Current report

23. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 27

    Current report

24. ROUTINESCHEDULE 13G/ATonix Pharmaceuticals Holding Corp.TNXPMay 15

    Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

    Point72 Asset Management, L.P., filed by

25. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 15

    Current report

26. ROUTINESCHEDULE 13GTonix Pharmaceuticals Holding Corp.TNXPMay 15

    Ownership stake disclosure by Sirenia Capital Management LP

    Sirenia Capital Management LP, filed by

27. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPMay 14

    8 insider filings

    Richard Newcomb Stillwell, insider filing for TNXP

    Show all 8

    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14
    • 4Insider filing for TNXPMay 14

    Richard Newcomb Stillwell, reporting

28. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 11

    Current report

29. NOTABLE10-QTonix Pharmaceuticals Holding Corp.TNXPMay 11

    Quarterly report

30. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 7

    Current report

31. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 6

    Current report

32. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMay 1

    Current report

33. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPApr 29

    Current report

34. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPApr 23

    Current report

35. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPApr 1

    Seth Lederman, insider filing for TNXP

    Seth Lederman, reporting

36. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMar 31

    Current report

37. ROUTINEDEF 14ATonix Pharmaceuticals Holding Corp.TNXPMar 30

    Proxy statement

38. ROUTINESCHEDULE 13G/ATonix Pharmaceuticals Holding Corp.TNXPMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

39. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMar 26

    Current report

40. ROUTINEPRE 14ATonix Pharmaceuticals Holding Corp.TNXPMar 20

    Preliminary proxy statement

41. ROUTINE4Tonix Pharmaceuticals Holding Corp.TNXPMar 18

    Seth Lederman, insider filing for TNXP

    Seth Lederman, reporting

42. ROUTINE8-KTonix Pharmaceuticals Holding Corp.TNXPMar 18

    Current report

Older filings on EDGAR